Go to deals
Healthcare | TMT

p-value Group has been acquired by Publicis Groupe

p-value Group, one of the largest independent medical communications agencies in North America, has been acquired by Publicis Groupe (ENXTPA:PUB) for its strong strategic fit, global scale and cultural alignment. The acquisition enhances Publicis Groupe’s medical communications capabilities in the USA and supports its broader strategy of integrating science-first solutions across its global network.

Founded in 2004 by Linda Corvari, p-value is a leading full-service provider of medical and scientific communications, serving marquee clients across the life sciences sector. The company specializes in medical strategy, scientific communications, content development and speaker bureau management, earning a strong reputation for scientific rigor, exceptional client service and a culture of excellence. p-value maintains diverse and expanding expertise across therapeutic areas, with particularly strong experience in dermatology.

Publicis Groupe, founded in 1926 and headquartered in Paris, France, is the world's second-largest advertising holding company by revenue. The group offers a broad range of services, including traditional and digital advertising, public relations and consulting. It employs approximately 108,000 people worldwide, with over 80% of its revenue generated from developed markets, particularly North America and Europe.

Oaklins Intrepid in Los Angeles acted as the exclusive sell-side advisor in this transaction, highlighting the team’s deep domain expertise in the pharmaceutical services sector and broader marketing agency landscape.

Parties

Talk to the deal team

Adam Abramowitz

Managing Director
Los Angeles, United States
Oaklins Intrepid

Greg Passani

Associate Director
Los Angeles, United States
Oaklins Intrepid

Related deals

UKAT Group has acquired Bayberry Limited
Private Equity | Healthcare

UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

Learn more
Medicija has acquired Saulės Šeimos Medicinos Centras
Healthcare

Medicija has acquired Saulės Šeimos Medicinos Centras

Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Learn more
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Healthcare

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Learn more